Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis-Reference-Cited by-同舟云学术

Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis

Published:2014-09-15 Issue:1 Volume:35 Page:90-100
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Calleja Jose L.¹,Pascasio Juan M.²,Ruiz-Antorán Belén³,Gea Francisco⁴,Bárcena Rafael⁵,Larrubia Juan R.⁶,Pérez-Álvarez Ramón⁷,Sousa Jose M.²,Romero-Gómez Manuel⁸,Solá Ricard⁹,de la Revilla Juan¹,Crespo Javier¹⁰,Navarro Jose M.¹¹,Arenas Juan I.¹²,Delgado Manuel¹³,Fernández-Rodríguez Conrado M.¹⁴,Planas Ramon¹⁵,Buti Maria¹⁶,Forns Xavier¹⁷,

Affiliation:

1. Department of Gastroenterology and Hepatology; University Hospital Puerta de Hierro Majadahonda; IDIPHIM and CIBEREHD; Madrid Spain

2. Unit for Clinical Management of Digestive Diseases; H. Virgen del Rocío, IBIS and CIBEREHD; Sevilla Spain

3. Department of Clinical Pharmacology; University Hospital Puerta de Hierro Majadahonda; IDIPHIM; Madrid Spain

4. Department of Gastroenterology and Hepatology; University Hospital La Paz; Madrid Spain

5. Department of Gastroenterology and Hepatology; University Hospital Ramón y Cajal; Madrid Spain

6. Gastroenetrology Section; Guadalajara University Hospital; University of Alcalá; Madrid Spain

7. Department of Gastroenterology and Hepatology; Asturias Central Hospital University; Madrid Spain

8. Unit for Clinical Management of Digestive Diseases and CIBERehd; Valme University Hospital; University of Seville; Sevilla Spain

9. Hepatology Unit; Hospital del Mar; Universitat Autònoma de Barcelona; Barcelona Spain

10. Deparment of Gastroenterology and Hepatology; Hospital Universitario Marqués de Valdecilla; IDIVAL; Santander Spain

11. Department of Gastroenterology and Hepatology; Hospital Costa del Sol. Marbella; Málaga Spain

12. Department of Gastroenterology and Hepatology; University Hospital Donostia; San Sebastian Spain

13. Department of Gastroenterology and Hepatology; University Hospital LA Coruña; LA Coruña Spain

14. Gastroenterology Unit; Hospital Universitario Fundación Alcorcon; Alcorcon Spain

15. Department of Gastroenterology and Hepatology; Hospital Germans Trias i Pujol and CIBEREHD; Barcelona Spain

16. Liver Unit; Vall d'Hebron University Hospital and CIBEREHD; Barcelona Spain

17. Liver Unit; Hospital Clinic; IDIPABS and CIBEREHD; Barcelona Spain

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12656/fullpdf

Reference11 articles.

1. Natural history of acute and chronic hepatitis C;Maasoumy;Best Pract Res Clin Gastroenterol,2012

2. Treating viral hepatitis C: efficacy, side effects, and complications;Manns;Gut,2006

3. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

4. Boceprevir for previously treated chronic HCV genotype 1 infection (RESPOND-2);Bacon;N Engl J Med,2011

5. Boceprevir for untreated chronic HCV genotype 1 infection;Poordad;N Engl J Med,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection;Journal of Immunology Research;2020-03-16

2. Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience;Journal of Interferon & Cytokine Research;2017-08

3. Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study;Clinics;2017-06-03

4. Do disparities between populations in randomized controlled trials and the real world lead to differences in outcomes?;Journal of Comparative Effectiveness Research;2017-01

5. Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon;PLOS ONE;2016-11-18